Brief: Metis Techbio Noted Media Report Alleging CSRC Issued Supplemental Information Requests To Company
May 26 (Reuters) - Metis TechBio Co Ltd 7666.HK: NOTED CERTAIN MEDIA REPORT ALLEGING THAT CSRC HAS ISSUED SUPPLEMENTAL INFORMATION REQUESTS TO COMPANY SAYS MEDIA REPORT INFORMATION IS FACTUALLY INACCURATE AND MISLEADING HAS NOT RECEIVED CSRC REQUEST FOR SUPPLEMENTAL INFORMATION RESERVES RIGHT TO INITIATE LEGAL PROCEEDINGS TO PROTECT INTERESTS Further company coverage: 7666.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metis TechBio
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
HK-listed Metis TechBio climbs on deal with Eli Lilly
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion (updated)
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech